OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Ameliorative effect of montelukast against STZ induced diabetic nephropathy: targeting HMGB1, TLR4, NF-κB, NLRP3 inflammasome, and autophagy pathways
Ahmed Awad, Sally L. Elshaer, Rajashekhar Gangaraju, et al.
Inflammopharmacology (2023) Vol. 32, Iss. 1, pp. 495-508
Open Access | Times Cited: 12
Ahmed Awad, Sally L. Elshaer, Rajashekhar Gangaraju, et al.
Inflammopharmacology (2023) Vol. 32, Iss. 1, pp. 495-508
Open Access | Times Cited: 12
Showing 12 citing articles:
Cell and molecular targeted therapies for diabetic retinopathy
Shivakumar K Reddy, Vasudha Devi, Amritha T. M. Seetharaman, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 7
Shivakumar K Reddy, Vasudha Devi, Amritha T. M. Seetharaman, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 7
Review on the role of nucleotide-binding oligomerization domain-like receptor protein 3 (NLRP3) inflammasome pathway in diabetes: mechanistic insights and therapeutic implications
Abhishek Satheesan, Janardanan Kumar, K.V. Leela, et al.
Inflammopharmacology (2024) Vol. 32, Iss. 5, pp. 2753-2779
Closed Access | Times Cited: 6
Abhishek Satheesan, Janardanan Kumar, K.V. Leela, et al.
Inflammopharmacology (2024) Vol. 32, Iss. 5, pp. 2753-2779
Closed Access | Times Cited: 6
High-mobility group box 1 and its related receptors: potential therapeutic targets for contrast-induced acute kidney injury
Changhua Mo, Qili Huang, Lixia Li, et al.
International Urology and Nephrology (2024) Vol. 56, Iss. 7, pp. 2291-2299
Closed Access | Times Cited: 4
Changhua Mo, Qili Huang, Lixia Li, et al.
International Urology and Nephrology (2024) Vol. 56, Iss. 7, pp. 2291-2299
Closed Access | Times Cited: 4
Afobazole alleviates streptozotocin-induced diabetic nephropathy in rats via hypoglycemic, antioxidant, anti-inflammatory, and anti-apoptotic properties: Role of the S1R/Nrf2 antioxidant axis
Alaa S. Wahba, Dalia M. Asal, Noha M. Mesbah, et al.
Life Sciences (2025) Vol. 363, pp. 123410-123410
Closed Access
Alaa S. Wahba, Dalia M. Asal, Noha M. Mesbah, et al.
Life Sciences (2025) Vol. 363, pp. 123410-123410
Closed Access
Crosstalk between ferroptosis and innate immune in diabetic kidney disease: mechanisms and therapeutic implications
Jinyang Wang, Haonan Shi, Ye Seul Yang, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Jinyang Wang, Haonan Shi, Ye Seul Yang, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Methanolic extract of Merremia emarginata (Burm. f.) Hallier f. attenuates renal damage in streptozotocin-induced diabetic nephropathy in rats
Reema Mitra, Payal Mittal, Pradeep Goyal
Obesity Medicine (2024) Vol. 48, pp. 100544-100544
Closed Access | Times Cited: 2
Reema Mitra, Payal Mittal, Pradeep Goyal
Obesity Medicine (2024) Vol. 48, pp. 100544-100544
Closed Access | Times Cited: 2
Targeting Autophagy: A Promising Therapeutic Strategy for Diabetes Mellitus and Diabetic Nephropathy
Qirui Li, Huiying Xu, Rui-Ting Ma, et al.
Diabetes Therapy (2024) Vol. 15, Iss. 10, pp. 2153-2182
Open Access | Times Cited: 2
Qirui Li, Huiying Xu, Rui-Ting Ma, et al.
Diabetes Therapy (2024) Vol. 15, Iss. 10, pp. 2153-2182
Open Access | Times Cited: 2
Protective effect of leukotriene receptor antagonist, montelukast, against cyclophosphamide-induced placental toxicity via modulation of NLRP3/IL-1β signaling pathway in rats
Walaa Yehia Abdelzaher, Salwa A. Ibrahim, Seham A. Abdel-Gaber, et al.
International Immunopharmacology (2024) Vol. 139, pp. 112700-112700
Closed Access | Times Cited: 1
Walaa Yehia Abdelzaher, Salwa A. Ibrahim, Seham A. Abdel-Gaber, et al.
International Immunopharmacology (2024) Vol. 139, pp. 112700-112700
Closed Access | Times Cited: 1
Cysteinyl Leukotriene Receptor Antagonism by Montelukast to Treat Visual Deficits
Amritha T. M. Seetharaman, Caroline Owens, Rajashekhar Gangaraju
Journal of Ocular Pharmacology and Therapeutics (2024)
Closed Access | Times Cited: 1
Amritha T. M. Seetharaman, Caroline Owens, Rajashekhar Gangaraju
Journal of Ocular Pharmacology and Therapeutics (2024)
Closed Access | Times Cited: 1
Cysteine Leukotriene Receptor Antagonist-Montelukast Effects on Diabetic Retinal Microvascular Endothelial Cells Curtail Autophagy
Ahmed Awad, Amritha T. M. Seetharaman, Mohammad Shahadat Hossain, et al.
Investigative Ophthalmology & Visual Science (2024) Vol. 65, Iss. 13, pp. 15-15
Open Access | Times Cited: 1
Ahmed Awad, Amritha T. M. Seetharaman, Mohammad Shahadat Hossain, et al.
Investigative Ophthalmology & Visual Science (2024) Vol. 65, Iss. 13, pp. 15-15
Open Access | Times Cited: 1
CysLTR1 antagonism by montelukast can ameliorate diabetes-induced aortic and testicular inflammation
Ahmed Awad, Sally L. Elshaer, Rajashekhar Gangaraju, et al.
International Immunopharmacology (2023) Vol. 125, pp. 111127-111127
Closed Access | Times Cited: 3
Ahmed Awad, Sally L. Elshaer, Rajashekhar Gangaraju, et al.
International Immunopharmacology (2023) Vol. 125, pp. 111127-111127
Closed Access | Times Cited: 3
Toll-Like Receptors and Diabetic Nephropathy: A Review of Recent Advances
Mohammad Sadra Gholami Chahkand, Yasaman Tavakoli, Ava Aghakhani, et al.
Turkish Journal of Immunology (2024), pp. 35-55
Open Access
Mohammad Sadra Gholami Chahkand, Yasaman Tavakoli, Ava Aghakhani, et al.
Turkish Journal of Immunology (2024), pp. 35-55
Open Access
